This week, I’m rerunning some popular posts while I prepare for this Friday’s live video webinar: Drug Channels Quarterly Update: Patients, Payers, and PBMs.
Click here to see the original post and comments from January 2021.
It was another year of unexpected drug price developments.
In 2020, brand-name drug net prices dropped for the third consecutive year. Meanwhile, brand-name drug list prices grew at their slowest rate in at least 20 years. See our updated analysis below.
I also review the factors behind declining brand-name drug prices. These factors are firmly in place for 2021.
.
Our new Congress may try tackle drug prices in the new year. Let’s hope that their policy perceptions catch up to today’s realities.
Source: Post feed
